LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-21
DOI
10.1002/jcp.28911
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U
- (2018) Xueying Yang et al. CANCER LETTERS
- miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipoma
- (2018) Yi Cai et al. LABORATORY INVESTIGATION
- Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4
- (2018) P. Zhao et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
- (2017) S.B. Coburn et al. INTERNATIONAL JOURNAL OF CANCER
- Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression
- (2017) Qiushuang Xiong et al. Cell and Bioscience
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
- (2016) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
- (2016) Haiyang Zhang et al. Protein & Cell
- BCL2L11/Bim as a dual-agent regulating autophagy and apoptosis in drug resistance
- (2015) Yun Dai et al. Autophagy
- Diminution of miR-340-5p levels is responsible for increased expression of ABCB5 in melanoma cells under oxygen-deprived conditions
- (2015) Michal Wozniak et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal Cancer
- (2015) I. Meinhold-Heerlein et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- miRNA Expression in Human Intestinal Caco-2 Cells is Comparably Regulated by cis - and trans -Fatty Acids
- (2015) Solveigh Köpke et al. LIPIDS
- Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer
- (2014) Xiaoping He et al. INTERNATIONAL JOURNAL OF CANCER
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer
- (2014) Brian Gloss et al. Molecular Cancer
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- BCL2L11/BIM
- (2012) Shouqing Luo et al. Autophagy
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation